Importantly, EZH2-binding sites also exhibited progressive increases in DNAm in breast cancer compared with normal-adjacent tissue (Fig. 4d), and although this was also true for CTCF-binding sites, the changes were more subtle (Supplementary Fig. 12D). The gene discussed is EZH2; the disease is breast cancer.